Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN79479093) titled 'Hereditary pancreatic cancer early surveillance program' on Feb. 6.
Study Type: Observational
Study Design:
Prospective, multicentre, longitudinal surveillance and sample-collection program
Primary Sponsor: Univerzitetni klinicni center Maribor
Condition:
Pancreatic ductal adenocarcinoma (PDAC)
Cancer
Intervention:
The study is designed as a prospective, multicentre, non-interventional, longitudinal observational surveillance and sample-collection programme in adults with increased hereditary and/or familial risk of pancreatic ductal adenocarcinoma (PDAC), with additional inclusion of newly diagnosed, treat...